Utilisation of Foreign Clinical Data in Japanese New Drug Approval Review: On What Basis Did the Regulatory Agency Accept Them?

Author： Shunsuke Ono

Publisher： Adis International

ISSN： 1364-9027

Source： International Journal of Pharmaceutical Medicine, Vol.18, Iss.3, 2004-01, pp. : 159-165

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Are orphan drugs reaching patients who require them?

Inpharma, Vol. 1, Iss. 1629, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

A Role for Two-Stage Pharmacoeconomic Appraisal?: Is There a Role for Interim Approval of a Drug for Reimbursement Based on Modelling Studies with Subsequent Full Approval Using Phase III Data?

By Hill S.

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 761-767

Adis International

Access to resources Recommend Favorite

Why Did Drug Spending Increase During the 1990s?: A Decomposition Based on Swedish Data

By Gerdtham U-G.

PharmacoEconomics, Vol. 22, Iss. 1, 2004-01 ,pp. : 29-42

Adis International

Access to resources Recommend Favorite

Morphological Brain Changes in Depression: Can Antidepressants Reverse Them?

By Miguel-Hidalgo J.J. Rajkowska G.

CNS Drugs, Vol. 16, Iss. 6, 2002-01 ,pp. : 361-372

Adis International

Access to resources Recommend Favorite

Is the UK government delaying approval for new cancer drugs?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 649, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite